Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer
of smart baby monitoring, today announces the appointment of Marc
Stoll to the Company’s Board of Directors. Stoll is currently an
Investment Partner at Eclipse, a strategic investment firm focused
on advancing the Industrial Evolution. His experience spans more
than 25 years across the global finance and technology industries,
and his expertise in leading corporate strategy and operational
excellence will help bolster Owlet’s future ventures and growth
potential.
"I’m thrilled to join Owlet’s Board of Directors after spending
time becoming very familiar with the brand and products, its
life-changing mission and amazing customers, and the company’s
incredible team across the globe,” said Marc Stoll. “The entire
Owlet community is strong, and I look forward to helping guide this
company in its next chapter of advancement in medical grade,
at-home infant health monitoring.”
Prior to Eclipse, Stoll was President and COO at Nextiva and has
more than two decades of experience combining his financial and
technology expertise derived from time as CFO at Anaplan and as
Vice President of Worldwide Sales Finance at Apple. Stoll also
served as Corporate Controller at CA, Inc. and as Head of
Technology Equity Research at Julius Baer Investment Management. He
has served on the public boards of Arista Networks, Earthlink and
Windstream, and on private boards as an investor and advisor.
Owlet values Stoll’s strong operational, financial, and consumer
experience in order to accelerate the Company’s global growth
strategies in its consumer and medical product distribution
channels. Stoll’s personal experience with remote patient
monitoring and his passion for life-impacting health technologies
make him a valuable addition to Owlet’s Board.
"I’ve had the pleasure of working with Marc during the recent
months, and I believe his appointment to Owlet’s Board of Directors
will help us continue on our growth trajectory,” said Kurt Workman,
Owlet CEO and Co-Founder. “Marc, as a part of Eclipse, has proven
himself to be a beneficial resource with his operational and
consumer product experience. Now, as a Board member, I see him
working closely with our current directors to help facilitate our
progress with go-to-market strategy for our first FDA-cleared
pulse-oximetry medical device, BabySat™, and future product
developments. I’m excited to continue our work together and see the
value Marc will add to our Board.”
Stoll will be the replacement designee of Eclipse, which
maintains the right to designate up to two directors as a result of
the Company’s February 2023 preferred stock financing, replacing
Jayson Knafel who resigned from Owlet’s Board and stepped away as a
Partner of Eclipse into a full-time CFO role.
About Owlet, Inc.
Owlet was founded by a team of parents in 2012. Owlet’s mission
is to empower parents with the right information at the right time,
to give them more peace of mind and help them find more joy in the
journey of parenting. Owlet’s digital parenting platform aims to
give parents real-time data and insights to help parents feel
calmer and more confident. Owlet believes that every parent
deserves peace of mind and the opportunity to feel their
well-rested best. Owlet also believes that every child deserves to
live a long, happy, and healthy life, and is working to develop
products to help further that belief. To learn more, visit
www.owletcare.com.
About Eclipse
With over $4 billion in assets under management, 70-plus
portfolio companies, and a team of investors with deep operating
expertise in technology, manufacturing, supply chain, logistics,
healthcare, and consumer products, Eclipse is a leading U.S.
venture capital firm. Its leadership team has the experience
necessary to create and scale complex operations. Eclipse partners
with exceptional companies that make physical industries more
efficient, resilient, and profitable. For more information, visit
www.eclipse.vc.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
(the “Reform Act”). All statements contained in this press release
that do not relate to matters of historical fact should be
considered forward-looking statements, including, without
limitation, statements regarding the Company’s growth prospects,
expanded product offerings and the impacts of new leadership. In
some cases, you can identify forward-looking statements by terms
such as “estimate,” “may,” “believes,” “plans,” “expects,”
“anticipates,” “intends,” “goal,” “potential,” “upcoming,”
“outlook,” “guidance,” the negation thereof, or similar
expressions, although not all forward-looking statements contain
these identifying words. Forward-looking statements are based on
the Company’s expectations at the time such statements are made,
speak only as of the dates they are made and are susceptible to a
number of risks, uncertainties and other factors. For all such
forward-looking statements, the Company claims the protection of
the safe harbor for forward-looking statements contained in the
Reform Act. The Company’s actual results, performance or
achievements may differ materially from any future results,
performance or achievements expressed or implied by our
forward-looking statements. Many important factors could affect the
Company’s future results and cause those results to differ
materially from those expressed in or implied by the Company’s
forward-looking statements. Such factors include, but are not
limited to, (i) the regulatory pathway for Owlet’s products,
including submissions to, actions taken by and decisions and
responses from regulators, such as the FDA and similar regulators
outside of the United States, as well as Owlet’s ability to obtain
and maintain regulatory approval or certification for our products
and other regulatory requirements and legal proceedings; (ii)
Owlet’s competition and the Company’s ability to profitably grow
and manage growth; (iii) the Company’s ability to enhance future
operating and financial results or obtain additional financing to
continue as a going concern; (iv) Owlet’s ability to obtain
additional financing in the future, as well risks associated with
the Company’s current loan and debt agreements, including
compliance with debt covenants, restrictions on the Company’s
access to capital, the impact of the Company’s overall debt levels
and the Company’s ability to generate sufficient future cash flows
to meet Owlet’s debt service obligations and operate Owlet’s
business; (v) the ability of Owlet to implement strategic
initiatives, reduce costs, grow revenues, develop and launch new
products, innovate and enhance existing products, meet customer
demands and adapt to changes in consumer preferences and retail
trends; (vi) Owlet’s ability to acquire, defend and protect its
intellectual property and satisfy regulatory requirements,
including but not limited to requirements concerning privacy and
data protection, breaches and loss, as well as other risks
associated with Owlet’s digital platforms and technologies; (vii)
Owlet’s ability to maintain relationships with customers,
manufacturers and suppliers and retain Owlet’s management and key
employees; (viii) Owlet’s ability to upgrade and maintain its
information technology systems; (ix) changes in applicable laws or
regulations; (x) the impact of and disruption to Owlet’s business,
financial condition, operations, supply chain and logistics due to
economic and other conditions beyond the Company’s control, such as
health epidemics or pandemics, macro-economic uncertainties, social
unrest, hostilities, natural disasters or other catastrophic
events; (xi) the possibility that Owlet may be adversely affected
by other economic, business, regulatory, competitive or other
factors, such as changes in discretionary consumer spending and
consumer preferences; and (xii) other risks and uncertainties set
forth in the Company’s other releases, public statements and
filings with the U.S. Securities and Exchange Commission (“SEC”),
including those identified in the “Risk Factors” section of the
Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2022, as updated in the Company’s Quarterly Reports on
Form 10-Q for the quarterly periods ended March 31, 2023 and June
30, 2023 and as any such factors may be updated from time to time
in the Company’s other filings with the SEC. All such
forward-looking statements attributable to the Company or any
person acting on the Company’s behalf are expressly qualified in
their entirety by the cautionary statements contained or referred
to above. Moreover, the Company operates in an evolving
environment. New risk factors and uncertainties may emerge from
time to time, and factors that the Company currently deems
immaterial may become material, and it is impossible for the
Company to predict such events or how they may affect Owlet. Except
as required by law, the Company assumes no obligation to update any
forward-looking statements after the date of this press release,
whether because of new information, future events or otherwise,
although Owlet may do so from time to time. The Company does not
endorse any projections regarding future performance that may be
made by third parties.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230816580012/en/
Mike Cavanaugh Westwicke/ICR Phone: +1.617.877.9641
mike.cavanaugh@westwicke.com
Sandbridge Aquisition (NYSE:OWLT)
過去 株価チャート
から 5 2024 まで 6 2024
Sandbridge Aquisition (NYSE:OWLT)
過去 株価チャート
から 6 2023 まで 6 2024